Corporate Update – Curtiss‑Wright Corp Annual General Meeting
The 2026 annual general meeting of Curtiss‑Wright Corp has been scheduled for 25 November. The company’s board has issued an official notice and proxy form that detail the agenda and procedural information for shareholders.
Meeting Format and Participation
Curtiss‑Wright Corp will conduct the meeting in a hybrid format, permitting shareholders to attend either in person at the corporate office or online through the company’s designated platform. Shareholders are urged to log in early to complete registration and to cast their votes on the agenda items. The notice provides detailed instructions for proxy voting and for submitting inquiries to the board and auditors.
Agenda Highlights
| Item | Description |
|---|---|
| Financial Report | Presentation of the financial statements for the year ended 30 June 2026. |
| Directors’ Report | Summary of board activities, strategic initiatives, and compliance matters. |
| Auditor’s Report | Independent assessment of the financial statements and internal controls. |
| Remuneration Report | Non‑binding resolution on executive compensation, detailing the remuneration framework and its linkage to performance metrics. |
| Director Appointments | Confirmation of re‑elections for Mr Mark Conway, Mr Thomas Culver, and Ms Jayne Shaw, all of whom have prior board experience or current appointments. |
| Capital‑raising Resolution | Approval of an additional 10 % placement capacity under ASX Listing Rule 7.1A and ratification of two prior share issues tied to a strategic alliance with Sigma Healthcare. |
Executive Remuneration
The remuneration report outlines the company’s executive compensation strategy, emphasizing alignment with long‑term shareholder value. The non‑binding nature of the resolution reflects the board’s intent to maintain flexibility while ensuring transparency and accountability.
Director Re‑Elections
All candidate directors have been recommended for re‑appointment. The chairman has indicated a proxy vote in favour of each resolution, reinforcing continuity in governance and strategic direction.
Capital‑Raising Strategy
The special resolution to increase placement capacity by 10 % enables Curtiss‑Wright Corp to issue additional equity securities, providing greater flexibility for future capital needs. The resolution also ratifies two earlier share issuances under a partnership with Sigma Healthcare, a move that may influence the company’s capital structure and available equity for subsequent offerings.
Governance and Shareholder Engagement
The board underscores its commitment to routine governance practices, including timely disclosure, robust audit oversight, and shareholder engagement. All voting procedures and meeting conduct will adhere to the guidelines set out in the notice. Shareholders are encouraged to participate in the meeting, whether online or in person, to exercise their rights and influence the company’s strategic direction.
